HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,280,000 | -34.8% | 400,000 | -34.9% | 0.04% | -34.0% |
| Q1 2023 | $23,448,660 | +26.2% | 614,000 | +88.1% | 0.05% | +20.5% |
| Q4 2022 | $18,577,850 | -11.6% | 326,500 | -59.2% | 0.04% | -17.0% |
| Q3 2020 | $21,024,000 | -21.6% | 800,000 | -20.0% | 0.05% | -23.2% |
| Q2 2020 | $26,810,000 | +112.9% | 1,000,000 | +42.9% | 0.07% | +81.6% |
| Q1 2020 | $12,593,000 | -36.9% | 700,000 | -37.8% | 0.04% | -22.4% |
| Q4 2019 | $19,946,000 | +71.5% | 1,125,000 | +50.0% | 0.05% | +69.0% |
| Q3 2019 | $11,633,000 | +50.5% | 750,000 | +66.7% | 0.03% | +52.6% |
| Q2 2019 | $7,731,000 | +220.1% | 450,000 | +200.0% | 0.02% | +216.7% |
| Q1 2019 | $2,415,000 | -52.3% | 150,000 | -40.0% | 0.01% | -45.5% |
| Q4 2017 | $5,065,000 | +16.6% | 250,000 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $4,343,000 | +4.2% | 250,000 | -23.1% | 0.01% | +10.0% |
| Q2 2017 | $4,167,000 | +221.5% | 325,000 | +225.0% | 0.01% | +233.3% |
| Q1 2017 | $1,296,000 | -45.6% | 100,000 | -46.7% | 0.00% | -57.1% |
| Q1 2014 | $2,384,000 | – | 187,584 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |